Sulpiride

Alternative names

ADA2A_HUMAN, ADRA2, ADRA2A, ADRA2R, ADRAR, Adrenergic alpha 2A receptor, Alpha 2AAR subtype C10, Alpha-2 adrenergic receptor subtype C10, Alpha-2A adrenergic receptor, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, Alpha-2AAR, CA 1, CA 12, CA 2, CA 7, CA VA, CA VB, CA-I, CA-II, CA-IX, CA-VI, CA-VII, CA-XII, CA5, CA5B, CA6, CA9, CAB, CAC, CAH12_HUMAN, CAH1_HUMAN, CAH2_HUMAN, CAH5B_HUMAN, CAH6_HUMAN, CAH7_HUMAN, CAH9_HUMAN, CAV, Car 1, Car 2, Carbonate dehydratase I, Carbonate dehydratase II, Carbonate dehydratase IX, Carbonate dehydratase VA, Carbonate dehydratase VB, Carbonate dehydratase VI, Carbonate dehydratase VII, Carbonate dehydratase XII, Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 2, Carbonic anhydrase 5B, Carbonic anhydrase 5B, mitochondrial, Carbonic anhydrase 6, Carbonic anhydrase 7, Carbonic anhydrase 9, Carbonic anhydrase A, Carbonic anhydrase B, Carbonic anhydrase B, formerly, Carbonic anhydrase C, Carbonic anhydrase C, formerly, Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase IX, Carbonic anhydrase VA, Carbonic anhydrase VA mitochondrial, Carbonic anhydrase VB, Carbonic anhydrase VB, mitochondrial, Carbonic anhydrase VI, Carbonic anhydrase VII, Carbonic anhydrase XII, Carbonic dehydratase, Carbonic dehydratase VII, D(1B) dopamine receptor, D(2) dopamine receptor, D(2C) dopamine receptor, D(3) dopamine receptor, D(4) dopamine receptor, D(4) dopamine receptor (D(2C) dopamine receptor)., D(5) dopamine receptor, D1 beta dopamine receptor, D1B dopamine receptor, D2 dopamine receptor, D2DR, D2R, D4 dopamine receptor, D4DR, D5 dopamine receptor, DBDR, DRD 1B, DRD1L2, DRD2_HUMAN, DRD4_HUMAN, DRD5_HUMAN, Dopamine D2 receptor, Dopamine D3 receptor, Dopamine D4 receptor, Dopamine D5 receptor, Dopamine receptor D1B, Dopamine receptor D2, EC=4.2.1.1, ECK0125, Eag-related protein 1, Epididymis secretory protein Li 282, Ether a go go related potassium channel protein, Ether-a-go-go-related gene potassium channel 1, Ether-a-go-go-related protein 1, FLJ00280, FLJ00318, FLJ16020, FLJ16733, FLJ20151, GUSTIN, H-ERG, HEL-76, HEL-S-282, HsT18816, IMD42, JW0122, KCNH2_HUMAN, Kv11.1, LQT 2, MGC102720, MGC10601, MGC129539, MGC21256, MN, Membrane antigen MN, NR1F3, NR2B1, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 2 group B member 1, OTTHUMP00000022510, OTTHUMP00000058849, P54/58N, Potassium channel HERG, Potassium voltage gated channel subfamily H (eag related) member 2, Potassium voltage-gated channel subfamily H member 2, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RCC associated protein G250, RCC-associated antigen G250, RORG_HUMAN, RXR alpha1, RXRA_HUMAN, RZR GAMMA, RZRG, Renal cell carcinoma-associated antigen G250, Retinoic acid binding receptor gamma, Retinoic acid receptor RXR-alpha, Retinoid X nuclear receptor alpha, Retinoid X receptor alpha, Retinoid-related orphan receptor-gamma, Rorc, SQT1, Salivary carbonic anhydrase, Secreted carbonic anhydrase, T18816, TOR, Tumor antigen HOM-RCC-3.1.3, Voltage gated potassium channel, subfamily H, member 2, Voltage-gated potassium channel subunit Kv11.1, alpha-2-adrenergic receptor, platelet type, carbonic anhydrase 5A mitochondrial, carbonic anhydrase V mitochondrial, carbonic anhydrase VA mitochondrial1, carbonic anhydrase VI nirs variant 1, carbonic anhydrase VI nirs variant 3, dopamine receptor D5, eag homolog, epididymis luminal protein 76, hERG-1, mitochondrial, pMW1, yadF